Sign in
4

Changes in Ownership

MBX Biosciences, Inc. Filed Acc 0000950170-24-107527

President & CEO acquired 399,760 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Hawryluk P. Kent President & CEO 2024-09-16 Conversion +283,846 481,397 D
Hawryluk P. Kent President & CEO 2024-09-16 Conversion +115,914 398,277 I
Derivatives
Hawryluk P. Kent President & CEO 2024-09-16 Conversion · Series A Convertible Preferred Stock −2,015,681 0 D
Hawryluk P. Kent President & CEO 2024-09-16 Conversion · Series A Convertible Preferred Stock −345,705 0 I
Hawryluk P. Kent President & CEO 2024-09-16 Conversion · Series B Convertible Preferred Stock −1,396,762 0 D
Hawryluk P. Kent President & CEO 2024-09-16 Conversion · Series B Convertible Preferred Stock −76,969 0 I
Hawryluk P. Kent President & CEO 2024-09-16 Conversion · Series C Convertible Preferred Stock −970,873 0 I
Loading xslF345X05/ownership.xml…